Justin W. Yorke - Aug 5, 2022 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 5, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/4/2023, 04:29 PM
Date Of Original Report
Aug 9, 2022
Previous filing
Apr 4, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +1.17K +8.52% 14.9K Aug 5, 2022 Direct F1, F2
holding PCSA Common Stock 533K Aug 5, 2022 By Richland Fund, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 Previous filing inadvertently underreported shares beneficially owned by the reporting person.